Isabel L. R.
- Country
- Belgium
- Department
- Center for Vaccinology (CEVAC)
Research Overview
- Evaluation of a Live Attenuated Vaccine for Single Dose Administration in Patients with Rift Valley Fever Infection
- Efficacy, Safety, and Immunogenicity of mRNA-1647 Vaccine in Preventing Primary Cytomegalovirus Infection in CMV-Seronegative Females Aged 16-40
- Phase 1 Study on Safety, Tolerability, and Immunogenicity of Adjuvanted Universal Influenza Vaccine fH1/DSP-0546LP in Healthy Adults
Data & Insights
Has run more than one trial at 81 of 248 partner sites.
Specializations
Respiratory Infections
Focused on developing preventive solutions for respiratory syncytial virus (RSV) and human metapneumovirus (hMPV) in older adults. Conducts research on innovative pneumococcal conjugate vaccines and their effectiveness in preventing respiratory infections.
- RSV and hMPV Prevention
- Pneumococcal Disease
- Vaccine Co-administration Studies
Influenza Research
Specializes in evaluating novel adjuvanted influenza vaccines across different age groups. Investigates both traditional and mRNA-based influenza vaccines, with particular attention to efficacy in elderly populations.
- Novel Adjuvant Technologies
- Age-specific Vaccine Responses
- Seasonal Flu Prevention
Emerging Infectious Diseases
Conducts research on vaccines for various infectious diseases including cytomegalovirus, yellow fever, and Rift Valley fever. Explores preventive solutions for Group B streptococcus and hepatitis B infections.
- Viral Disease Prevention
- Bacterial Infections
- Therapeutic Vaccination
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.